2016 International Congress Archives - Page 148 of 207

DAT SPECT data of Parkinson’s disease patients with and without REM Sleep Pathology: A report from the DeNoPa cohort

M.L. Muntean, D. Leucuta, B. Mollenhauer, C. Trenkwalder, F. Sixel-Döring (Göttingen, Germany)
Dat-SPECT in multiple system atrophy (MSA)

I. Toyoshima, T. Hatakeyama, Y. Takeda, K. Obara, M. Kobsysdhi, C. Wada (Yurihonjo, Japan)
Day case initiation of subcutaneous apomorphine in people with Parkinson’s disease: A retrospective analysis from a UK teaching hospital

K. Nalamada, J. Cosgrove, P. Duggan-Carter, S. Jamieson, J. Alty (Leeds, United Kingdom)
DBS of the STN in 44 patients with Parkinson’s disease – Radiological and clinical outcome

R.C. Nickl, P. Fricke, S. Johannes, R.I. Ernestus, F. Steigerwald, M.M. Reich, V. Sturm, J. Volkmann, C. Matthies (Würzburg, Germany)
DBS outcomes in a mixed cohort of dystonia: A single center experience

O. Saeed, I. Haq, S.B. Tatter, A.W. Laxton, T. Wilson, M. Siddiqui (Winston Salem, NC, USA)
DBS programming requirements and longevity

M. Tagliati, E. Karst (Los Angeles, CA, USA)
DBS related on-state freezing of gait – A case series

Y.C. Tai, E. Everingham, D. Tsui, V. Fung, N. Mahant (Kaohsiung, Taiwan)
DBS targeting: Validation of 3T MR image guided targeting using post-mortem 17T MR microscopy

J.D. Hilliard, T. Morishita, C.H. Lee, S.J. Blackband, M.S. Okun, K.D. Foote (Gainesville, FL, USA)
De novo mutations in PDE10A cause childhood-onset chorea with bilateral striatal lesions

N.E. Mencacci, E.J. Kamsteeg, L. R'Bibo, D. Lynch, B. Balint, M. Willemsen, M. Adams, S. Wiethoff, J. Ng, E. Meyer, L. Veneziano, P. Giunti, D. Hughes, M. Carecchio, G. Zorzi, C. Barzaghi, B. Garavaglia, N. Nardocci, V. Salpietro, J. Hardy, A. Pittman, H. Houlden, M. Kurian, L. Vissers, N. Wood, K. Bhatia (Londond, United Kingdom)
Deceleration capacity of heart rate indicates autonomic dysfunction in patients with PSP

V. Ries, N. Mix, D. Vadasz, A. Bauer, W.H. Oertel (Marburg, Germany)
Decline in drawing ability associated with frontal dysfunction after subthalamic nucleus deep brain stimulation in Parkinson’s disease

S. Hirano, S. Furukawa, M. Asahina, T. Yamamoto, T. Uchiyama, Y. Yamanaka, Y. Higuchi, T. Horikoshi, T. Uno, N. Saeki, S. Kuwabara (Chiba, Japan)
Deep brain stimulation effect on the quality of life of individuals with Parkinson’s disease

A. Ayres, M. Ghisi, A.M. Freiry, B.S.F. Oliveira, A.F.S. Schuch, C.R.M. Rieder, M.R. Olchik (Porto Alegre, Brazil)
Deep brain stimulation in a Parkinsonian patient with sever psychiatric complication

T. Ichikawa, Y. Hashimoto, T. Obuchi, K. Kobayashi, H. Oshima (Ageo, Japan)
Deep brain stimulation in early stage Parkinson’s disease: Is it disease modifying?

M.L. Hacker, M. Turchan, J. Tonascia, P.E. Konrad, T.L. Davis, J.S. Neimat, F.T. Phibbs, A.L. Sternberg, D.M. Shade, L.T. Drye, D. Charles (Nashville, TN, USA)
Deep brain stimulation in the STN of a Parkinsonian rat model overexpressing human A53T α-synuclein in the substantia nigra – A proof of principle

T. Musacchio, M. Rebenstorff, F. Fluri, C. Kleinschnitz, J.M. Brotchie, J. Volkmann, J.B. Koprich, C.W. Ip (Würzburg, Germany)
Deep brain stimulation in the treatment of cerebellar tremor in young patients

A. Landi, A. Trezza, D. Pirillo, M. Pilleri, A. Antonini, E.P. Sganzerla (Monza, Italy)
Deep brain stimulation in three patients with dystonia and severe cerebellar atrophy

V. Gonzalez, L. Cif, E. Sanrey, E. Nerrant, F. Cyprien, M. Ros, E. Chanseng, T. Roujeau, P. Coubes (Montpellier, France)
Deep brain stimulation may lead to dramatic worsening of slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature

C. Laurencin, W. Meissner, C. Tranchant, T. Witjas, F. Viallet, P. Damier, T. Danaila, J.L. Houeto, A. Eusebio, S. Thobois (Lyon, France)
Deep brain stimulation of the dentate nucleus improves ataxia and modulates cortical excitability

C.C. França, M.J. Teixeira, D. Ciampi de Andrade, R. Galhardoni, V.R. Barboza, V. Silva, G. Lepski, E.R. Barbosa, R.G. Cury (São Paulo, Brazil)
Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks

C.A. Antoniades, P. Rebelo, C. Kennard, T. Aziz, A.L. Green, J.J. FitzGerald (Oxford, United Kingdom)
Deep brain stimulation of the locomotor mesencephalic region in rats with lesioned sensorimotor cortex: A model of functional motor recovery after stroke

F. Fluri, M.K. Schuhmann, C. Kleinschnitz, J. Volkmann (Würzburg, Germany)
Deep brain stimulation outcomes for dystonia in adult and pediatric patients at Gillette Children’s Specialty Healthcare

T. Feyma, S. Roiko, M. Gormley, A. Laine, J. Gettings, P. Graupman (Saint Paul, MN, USA)
Defective ubiquitinated mitochondria accumulation in aged Parkinsonian LRRK2^R1441G knockin mice

H.F. Liu, P.W.L. Ho, L.F. Li, G.C.T. Leung, C.S.C. Lam, M.H.W. Kung, D.B. Ramsden, S.L. Ho (Hong Kong, Hong Kong)
Defective visual perception in patients with Parkinson’s disease: The impairment of preattentive visual processing in the normal intellectual patients

Y. Higashi, T. Tabuchi, M. Tabata, E. Mori (Himeji, Japan)
Deficiency of HGprt in Lesch-Nyhan disease is associated with abnormal dopaminergic neurodevelopment in vivo

J.E. Visser, J.S. Witteveen, N.H.M. van Bakel, G.J.M. Martens, S.M. Kolk (Nijmegen, Netherlands)
Deficits in sensorimotor networks in functional movement disorders: A graph-theory based network analysis

C.W. Maurer, K. LaFaver, S. Tinaz, M. Hallett, S.G. Horovitz (Bethesda, MD, USA)
Defining the pathology underlying cortico-basal syndrome: A European study

R.C. Lamb, M.C. Darvell, J.D.S. Woodside, J.D. Rohrer, A.J. Lees, H.R. Morris (London, United Kingdom)
Deletions at 22q11.2 in idiopathic Parkinson’s disease: A combined analysis of GWAS data

K.Y. Mok, U. Sheerin, J. Simón-Sánchez, A. Salaka, L. Chester, V. Escott-Price, K. Mantripragada, K.M. Doherty, A.J. Noyce, N.E. Mencacci, S.J. Lubbe, International Parkinson's Disease Genomics Consortium (IPDGC), C.H. Williams-Gray, R.A. Barker, K.D. van Dijk, H.W. Berendse, P. Heutink, J.C. Corvol, F. Cormier, S. Lesage, A. Brice, K. Brockmann, C. Schulte, T. Gasser, T. Foltynie, P. Limousin, K.E. Morrison, C.E. Clarke, S. Sawcer, T.T. Warner, A.J. Lees, H.R. Morris, M.A. Nalls, A.B. Singleton, J. Hardy, A.Y. Abramov, V. Plagnol, N.M. Williams, N.W. Wood (London, United Kingdom)
Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV

N. Prinz, L. Wang, J. Stingl, M.D. Denkinger, P. Fasching, P.M. Jehle, S. Merger, S. Mühldorfer, A. Schuler, A. Zeyfang, M. Sharma, R.W. Holl (Ulm, Germany)
Dementia in Parkinson’s disease is associated with increased diffusivity in amygdala and external capsule

A. Umemura, T. Oeda, K. Yamamoto, M. Kohsaka, S. Tomita, K. Park, H. Sugiyama, H. Sawada (Kyoto, Japan)
Dementia in Parkinson’s disease: Is male gender a risk factor?

E. Cereda, R. Cilia, C. Klersy, C. Siri, A. Colombo, B. Pozzi, E. Reali, A.L. Zecchinelli, C.B. Mariani, S. Tesei, M. Canesi, G. Sacilotto, N. Meucci, M. Zini, I.U. Isaias, M. Barichella, E. Cassani, S. Glodwurm, G. Pezzoli (Pavia, Italy)
Demographic and phenotypic comparison of Huntington’s disease in Europe and North America: Data from REGISTRY and COHORT, two prospective observational cohort studies

M. Orth, J. Bronzova, C. Tritsch, R. Dorsay, J.M. Burgunder, A. Gemperli (Ulm, Germany)
Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

M. Salari (Isfahan, Islamic Republic of Iran)
Density of metabotropic glutamate receptors subtype 1 in de novo patients with Parkinson’s disease using ¹¹C-ITMM PET

M. Mishina, M. Suzuki, K. Ishii, M. Sakata, K. Wagetsuma, K. Ishibashi, J. Toyohara, M.R. Zhang, K. Kimura, K. Ishiwata (Kawasaki, Japan)
Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder

Y. Saitoh, Y. Mukai, T. Sakamoto, M. Murata (Tokyo, Japan)
Depression and apathy in restless legs syndrome

Y. Kaji, K. Ouchi, K. HIrata (Mibu, Japan)
Depression and clinical progression in spinocerebellar ataxias

S.H. Kuo, R.Y. Lo, K.P. Figueroa, S.M. Pulst, S. Perlman, G. Wilmot, C. Gomez, J. Schmahmann, H. Paulson, V.G. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, T. Ashizawa, S.H. Subramony (New York, NY, USA)
Depression, anxiety, and apathy in Parkinson’s disease: Insights from neuroimaging studies

M.C. Wen, L.L. Chan, L.C.S. Tan, E.K. Tan (Singapore, Singapore)
Depressive disorders in Parkinson’s disease and Alzheimer’s disease

D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)
Detailed evaluation of dyskinesias using multiple endpoints in a randomized, placebo-controlled trial of Parkinson’s disease patients with motor fluctuations

C. Kenney, K. Kieburtz, W. Olanow, S. Bandak (San Francisco, CA, USA)
Detailed proteomic analysis of early PD brain highlights altered expression of mitochondrial proteins as an important event in sporadic PD

S. Gandhi, C.E. Murray, W.E. Heywood, J.L. Holton, K. Mills, T. Revesz (London, United Kingdom)
Detecting brainstem changes in Parkinson’s disease using quantitative MRI

C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)
Detection of leucine-rich repeat kinase 2 in human biofluids

E. Mutez, W. Sibran, T. Comptdaer, P. Semaille, M. Drouyer, S. Bleuse, L. Defebvre, A. Destee, M.C. Chartier-Harlin, J.M. Taymans (Lille, France)
Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q.X. Yang (Hershey, PA, USA)
Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, Y. Watanabe, K. Hashimoto, T. Shingo, K. Kaga, C. Shibata-Yamaguchi, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)
Developing a new home monitoring device for dyskinesia in Parkinson’s disease

J.E. Alty, J. Cosgrove, M.A. Lones, S. Jamieson, P. Duggan-Carter, C. Peacey, C. Wicks, R.F. Naylor, A.J. Turner, S.L. Smith (Leeds, United Kingdom)
Developing palliative care clinics for patients with advanced Parkinson’s disease: Practical approaches, challenges, and experiences

C.L. Dietiker, N.B. Galifianakis, M. Katz, S.L. Heath (San Francisco, CA, USA)
Development and external validation of a prognostic model of mortality in Parkinson’s disease

A.D. Macleod, I. Dalen, O.B. Tysnes, J.P. Larsen, C.E. Counsell (Aberdeen, United Kingdom)
Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration

A. Di Marco, G. Auciello, A. Vecchi, D. Vignone, M.R. Battista, E. Bracacel, F. Bonelli, E. Nizi, E. Monteagudo, M. Beconi (Pomezia, Italy)
Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model

P.C. Bhatt, V. Kumar (New Delhi, India)
Development of a nanoherbaceutical formulation containing compound extracts from huperzia serrata, mucuna pruriens and withania somnifera for the prevention and treatment of Parkinson’s disease

V. Kumar, P.C. Bhatt (Allahabad, India)
Development of a tool for assessment of embarrassment due to dystonia

R. Verma, K.S. Anand (New Delhi, India)
Development of hyperkinesias after long term pallidal stimulation for dystonia

A. Wloch, G. Lütjens, C. Schrader, M. Manu, C. Blahak, J.K. Krauss (Hannover, Germany)
Development of the UK hereditary spastic paraplegia registry: Analysis of SPAST patients reveals high rate of psychiatric comorbidities

V. Chelban, A. Tucci, H. Houlden (Chisinau, Republic of Moldova)
Developmental movement patterns resemble movement disorder features in healthy babies and toddlers

M.J. Kuiper, R. Brandsma, R.J. Lunsing, H. Eggink, H. Burger, H.J. Ter Horst, A.F. Bos, D.A. Sival (Groningen, Netherlands)
Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease

A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)
Diagnostic accuracy of common bedside ataxia examination tests

R. Thompson, P. Woolman, D.E. Bhatti, A. Hellman, J.M. Bertoni, D. Torres-Russotto (Omaha, NE, USA)
Diagnostic performance of the Spanish version of the 19-items wearing-off questionnaire in Mexican patients with PD

D. Cruz-Fino, A. Alvarado-Bolaños, M. Rodríguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)
Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)
Diagnostic sensitivity and remote monitoring of motor and non-motor dysfunction in Parkinson’s disease

K. Muhammed, S. Arora, M. Hu, M. Husain (Oxford, United Kingdom)
Diagnostic value of a new coronal examination plane in transcranial nigral sonography and of additional M-mode tremor frequency determination for the differentiation of idiopathic Parkinson’s disease and essential tremor

L. Tönges, R. Daniel, D. Woitalla, S. Muhlack, R. Gold, C. Krogias (Bochum, Germany)
Diagnostic value of cardiac 123I-MIBG SPECT and CT co-registration in PD and MSA-P

C. Kaindlstorfer, F. Krismer, A. Fanciulli, S. Eschlböck, M. Nocker, S. Bösch, K. Mair, C. Scherfler, A. Djamshidian-Tehrani, C. Uprimny, E. Donnemiller, I. Virgolini, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)
Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis

M. Rossi, C. Terroba Chambi, A. Bril, P. Millar Vernetti, D. Cerquetti, A. Cammarota, M. Merello (Buenos Aires, Argentina)
Diaphragmatic dystonia in a patient that presents with Meige syndrome and disordered breathing

N. Licking, B. Farro (Portland, OR, USA)
Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)
Difference of REM sleep behavior disorder between the onset of before and after Parkinson’s disease

T. Nomura, Y. Inoue, K. Nakashima (Yonago, Japan)
Differences between responders and non-responders of Istradefylline for the wearing off in Parkinson’s disease

A. Yoritaka, H. Mori, N. Hattori (Saitoma, Japan)
Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)

M. Skorvanek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gershanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))
Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)
Differences in processing proprioceptive input from the neck muscles may explain the benefit from sensory tricks in patients with idiopathic cervical dystonia

F. Brugger, A. Peters, D. Georgiev, G. Kägi, B. Balint, K.P. Bhatia, B.L. Day (St. Gallen, Switzerland)
Differences of gut bacterial community relate to pathology progress in Parkinson’s disease

T. Minato, S. Hasegawa, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, A. Okamoto, T. Maeda, K. Ohno, M. Hirayama (Nagoya, Japan)
Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson’s disease: A resting-state fMRI study

H. Chen, Z. Wang, J. Fang, L. Gao, T. Feng (Beijing, People's Republic of China)
Differential clinical outcomes in unifocal vs. multifocal premotor rTMS for Parkinson’s disease: A randomized trial

M.C. Biagioni, A.Y. Son, S. Agarwal, G. Dacpano, M. Brys, P. Kumar, A. Cucca, J. Singleton-Garvin, R. Gilbert, A. Quartarone, A. DiRocco (New York, NY, USA)
Differential effects of tango, treadmill, and stretching interventions on gait in people with Parkinson’s disease

M.E. McNeely, R.P. Duncan, G.M. Earhart (St. Louis, MO, USA)
Differential expression of cerebral dopamine neurotrophic factor (CDNF) in the hippocampus and in the striatum of LRRK-2 mutant rat model of Parkinson’s disease

J. Varghese, K. Terpstra, S. Chiu, R. Mishra, Y. Bureau (London, ON, Canada)
Differential vulnerability to α-synuclein pathology among neuronal subpopulations

E. Luna, D.M. Riddle, V.M.Y. Lee, K.C. Luk (Philadelphia, PA, USA)
Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson’s disease

S.I. El-Jaafary, H.S. Abdel Tawab, M.Y. Elwash, H. Gabr, H.M. Saad Eldien (Cairo, Egypt)
Differentiating Parkinson’s disease from advanced essential tremor using EMG

M. Muthuraman, J. Raethjen, G. Deuschl, S. Groppa (Mainz, Germany)
Diffusion tensor imaging (DTI) within the primate caudate nucleus marks dopaminergic (DA) and serotonergic (5-HT) lesions

S. Thobois, E. Météreau, M. Beaudoin-Gobert, S. Duperrier, L. Tremblay, V. Sgambato-Faure (Bron, France)
Diffusion tensor imaging biomarkers of nigrostriatal neurodegeneration in early Parkinson’s disease

J.A. Pineda-Pardo, G. Foffani, J.A. Obeso (Madrid, Spain)
Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis with clinical considerations and neuroimaring parameters

C. Atkinson-Clement, S. Pinto, A. Eusebio, O. Coulon (Aix-en-Provence, France)
Diffusion tensor imaging of corticospinal tract, cingulum and corpus callosum in Parkinson’s disease (PD) patients

R. Guimarães, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)
Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls

R. Guimaraes, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)
Diffusion tensor metrics of thalamic degeneration and postural instability in Parkinson’s disease

M. Petrou, C. Davatzikos, M. Muller, R. Koeppe, R. Albin, K. Frey, N. Bohnen (Ann Arbor, MI, USA)
Digitally captured Archimedes spiral indices correlate with clinical assessment of dystonia severity

J.B. Ratliff, A. Mirallave, R. Ortega, A. Glickman, Q. Yu, D. Raymond, S. Bressman, S. Pullman, R. Saunders-Pullman (New York, NY, USA)
Digitizing tablet and Fahn-Tolosa-Marín tremor ratings have comparable minimum detectable change

R.J. Elble (Springfield, IL, USA)
Direct assessment of psychosocial measures using eye tracking technology in advanced ALS – Can preserved autonomy and psychological wellbeing modify disease course?

K. Linse, W. Rüger, M. Joos, H. Schmitz-Peiffer, A. Storch, A. Hermann (Dresden, Germany)
Direct comparisons for botulinum neurotoxins in movement disorders

R. Maggio, S. Lalli, A. Albanese (Rozzano, Italy)
DIRECT DBS: A prospective, multi-center clinical trial with blinding for a directional DBS lead

J. Volkmann, S. Chabardes, G.K. Steinke, S. Carcieri, N. Van Dyck (Wuerzberg, Germany)
Disability is an independent predictor of falls and recurrent falls in people with Parkinson’s disease without a history of falls: A one-year prospective study

L.R.S. Almeida, C. Sherrington, N.E. Allen, S.S. Paul, G.T. Valenca, J. Oliveira-Filho, C.G. Canning (Salvador, Brazil)
Discrimination of Parkinson’s disease participants from healthy controls using telephone-quality voice recordings

S. Arora, A. Tsanas (Oxford, United Kingdom)
Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)
Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson’s disease from OFF to fully ON

H. Shill, E.J. Pappert, A. Agro, B. Dzyngel, T. Bilbault, S. Isaacson, R. Hauser (Phoenix, AZ, USA)
Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry

T. Taguchi, K. Nanri, Y. Ueta, H. Terashi, H. Aizawa (Tokyo, Japan)
Disease-related variables effect on depression and anxiety level in Parkinson’s patients

T. Uyar, D. Sarikaya Varlik, A. Ercan, O.C. Cenker, I. Gungor Dogan (Rize, Turkey)
Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease

L. Ma, H. Chen, T. Feng (Beijing, People's Republic of China)
Disrupted motor memory in Parkinson’s disease

S. Voets, J.S. Brittain, M. Panouilleres, C. Miall, N. Jenkinson (Birmingham, United Kingdom)
Disruption of cerebellar connectivity in cervical dystonia

P. Filip, B. Martin (Brno, Czech Republic)
Disruption of circadian rhythm function and anti-oxidation via SIRT1-BMAL1 pathway in 6-OHDA induced Parkinson’s disease model

Y. Wang, S. Li, C. Mao, Y. Yang, F. Wang, C.F. Liu (Suzhou, People's Republic of China)
Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)
Dissecting the molecular mechanisms of Fyn-mediated levodopa induced dyskinesias

M.P. Bordone, M.A. Bernardi, A. Damianich, S. Sanz-Blasco, G. Gómez, I.R.E. Taravini, M.E. Avale, O.S. Gershanik, J.E. Ferrario (Buenos Aires, Argentina)
Distinguishing pseudo-dystonia from dystonia: A case series

L.E. Katus, S.J. Frucht (New York, NY, USA)
Distribution of oscillatory activities in MRI confirmed subthalamic nucleus subregions

M. Beudel, A. Oswal, A. Jha, T. Foltynie, L. Zrinzo, M. Hariz, P. Limousin, S. Derrey, H. Akram, L. Vladimir, P. Brown (Groningen, Netherlands)
Diurnal variation of levodopa plasma concentration in patients with Parkinson’s disease

M. Nagai, M. Kubo, H. Iwaki, R. Ando, H. Yabe, N. Nishikawa, M. Nomoto (Ehime, Japan)
Diverse effects of alpha-synuclein fibrils on various neuron cell lines, using different buffers

F. Aliakbari, D. Morshedi, A.A. Shabani, H. Mohammad Beigi, A. Tayaranian Marvian, P. Shariati, S.A. Shojaosadati, A.A. Saboury (Semnan, Islamic Republic of Iran)
DJ-1 regulates intracellular signaling in a highly cell type specific manner

F. Giesert, D.M. Vogt Weisenhorn, U. Hafen, A. Romanov, A. Kurz-Drexler, W. Wurst (Neuherberg, Germany)
Do different tic phenotypes have different responses to comprehensive behavioral intervention for tics (CBIT)?

W. Deeb, L. Almeida, H. Simpson, I. Malaty, M. Okun (Gainesville, FL, USA)
Do environmental factors influence the age at onset of Parkinson’s disease in LRRK2 G2019S carriers?

S. Elincx-Benizri, L. Greenbaum, G. Yahalom, T. Tsafnat, S. Israeli-Korn, O.S. Cohen, H. Strauss, S. May, R. Djaldetti, N. Warman Alaluf, S. Hassin-Baer (Ramat Gan, Israel)
Do mutations in the TGM6 (SCA35) gene cause early-onset Parkinson’s disease?

A. Westenberger, M. Svetel, N. Dragaševic, I. Brænne, V. Dobricic, A.A. Hicks, A. Tomic, N. Kresojevic, H. Pawlack, K. Grütz, A. Domingo, J. Erdmann, V.S. Kostic, C. Klein (Luebeck, Germany)
Do predictors of good response to deep brain stimulation in primary cervical movement disorders exist?

E. Sanrey, V. Gonzalez, L. Cif, F. Cyprien, E. Borgeais, J. Perez, M. Ros, P. Coubes (Montpellier, France)
Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)
Do-not-resuscitate utilization in inpatient Parkinson’s disease in the United States

A. Mahajan, A. Patel, G. Nadkarni, C. Sidiropoulos (Detroit, MI, USA)
Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?

H. Abboud, G. Genc, D. Reyes, N.R. Thompson, R. Cerejo, K. Wilson, A. Ahmed, M. Gostkowski, A. Machado, H.H. Fernandez (Cleveland, OH, USA)
Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up

R.A. Lawson, A.J. Yarnall, G.W. Duncan, D.P. Breen, T.K. Khoo, C.H. Williams-Gray, R.A. Barker, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)
Does distance walked after two minutes predict total 6 minute walk test distance in people with Parkinson’s disease?

R.P. Duncan, M.E. McNeely, G.M. Earhart (Saint Louis, MO, USA)
Does dopamine affect the selection of stepping actions in PD?

E. Mallia, C. Stummer, J. Rothwell, B.R. Bloem, V. Weerdesteyn (London, United Kingdom)
Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients

L. Lowry, B. Hammersley, M. Bonello, P. Byrne, N.A. Fletcher, J.O. Farah, P.R. Eldridge, S.H. Alusi (Liverpool, United Kingdom)
Does link between fatigue syndrome and camptocormia in patients with Parkinson’s disease exist?

V. Datieva, O. Levin (Moscow, Russia)
Does physical exercise influence the cognitive domains that predict dementia in Parkinson’s disease?

C.R.A. Silveira, E.A. Roy, B.N. Intzandt, Q.J. Almeida (Waterloo, ON, Canada)
Does repetitive transcranial magnetic stimulation (rTMS) affect cognitive function in Parkinson’s disease by modulating high-frequency brain oscillations: A magnetoencephalography (MEG) study

I. Buard, J. Shattuck, B.M. Kluger (Aurora, CO, USA)
Does VIM deep brain stimulation affect swallowing?

S. De Jesus, J. Hicks, L. Almeida, L. Shahgholi, A. Patterson, A. Bona, B. Ahmed, K. Hegland, M. Okun (Gainesville, FL, USA)
Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson’s disease center

S. Patel, X. Garcia, M.E. Mohammad, X.X. Yu, K. Vlastaris, K. O'Donnell, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)
Dopamine and task-dependent evolution of oscillatory activity in the subthalamic nucleus (STN) and coupling between the STN local field potential and muscle activity in Parkinson’s disease

U. Ramirez Pasos, R. Reese, F. Steigerwald, M. Reich, C. Matthies, I. Isaias, J. Volkmann (Wuerzburg, Germany)
Dopamine D3 receptor Ser9Gly variant is a risk factor for impulse control disorders in Parkinson’s disease

A. Kishore, S. Krishnamoorthy, R. Rajan, S. Sarma, M. Banerjee (Trivandrum, India)
Dopamine dysregulation syndrome /DDS/ in LCIG infusion: Successful treatment without interrupting the pump therapy

A. Tóth, H. Nagy, S. Funk, A. Takáts (Budapest, Hungary)
Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease

N.C. van Wouwe, D.O. Claassen, J.S. Neimat, S.A. Wylie (Nashville, TN, USA)
Dopamine reduces Parkinson’s tremor through increased thalamic inhibition

M.F. Dirkx, H.E. den Ouden, E. Aarts, M. Timmer, B.R. Bloem, I. Toni, R.C. Helmich (Nijmegen, Netherlands)
Dopamine transporter, depression and anxiety differences between tremor-predominant and non-tremulous PD are already evident within 2 years of PD diagnosis

Q. Hu, F. Zhou, C.P. Jedynak, L.S. Rosenthal, Z. Mari, B.M. Jedynak (Baltimore, MD, USA)
Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study

F.T. Liu, J.J. Ge, J.J. Wu, Z.T. Ding, C.T. Zuo, J. Wang (Shanghai, People's Republic of China)
Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson’s disease

V. Dibilio, A. Nicoletti, G. Mostile, S. Toscano, A. Luca, L. Raciti, R. Vasta, C.E. Cicero, D. Contrafatto, M. Zappia (Catania, Italy)
Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment

H. Murakami, A. Futamura, T. Kuroda, S. Ishigaki, M. Kezuka, K. Ono, M. Kawamura (Tokyo, Japan)
Dopaminergic medication affects choice bias in Parkinson’s disease

A.J.M. van Nuland, R.C.G. Helmich, M. Dirkx, H. Zach, B.R. Bloem, I. Toni, R. Cools, H.E.M. den Ouden (Nijmegen, Netherlands)
Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study

T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)
Dopaminergic medicines are alternative drugs for treatment of motor disorders in ischemic stroke

A. Azimov, R. Sadykov, G. Rakhimbaeva, S. Dadajonov, O. Azizova (Tashkent, Uzbekistan)
Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)
Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)
Dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behaviour disorder

R. De Marzi, K. Seppi, B. Högl, C. Müller, C. Scherfler, A. Stefani, A. Iranzo, E. Tolosa, J. Santamarìa, E. Gizewski, M. Schocke, C. Kremser, W. Poewe (Innsbruck, Austria)
Dosing of abobotulinumtoxinA and muscle selection in patients with simple patterns of cervical dystonia

V.P. Misra, R. Trosch, S. Om, P. Maisonobe (London, United Kingdom)
Double-blind, placebo-controlled trial of a fermented milk containing multiple probiotic strains and prebiotic fiber for constipation associated with Parkinson’s disease

E. Cereda, C. Pacchetti, C. Bolliri, E. Cassani, L. Iorio, C. Pusani, G. Pinelli, G. Privitera, I. Cesari, S.A. Faierman, R. Caccialanza, G. Pezzoli, M. Barichella (Pavia, Italy)
Dropped head syndrome in parkinsonism: Two treatable etiologies not to miss

P. Termsarasab, S.J. Frucht (New York, NY, USA)
Drp1 inhibition amelioratesα-synuclein-mediated neurodegeneration in rats

S. Bido, L. Arcuri, M. Helly, R. Fan, K. Tieu, E. Bezard (Bordeaux, France)
Drug induced parkinsonism: Role of functional imaging and follow up

A.S. Shetty, H.J. Shah, V.R. Lele, P.M. Wadia (Mumbai, India)
Drug safety in the pharmacotherapy of Parkinson’s disease

S. Müller-Rebstein, C. Trenkwalder, J. Ebentheuer, C. Culmsee, G. Höglinger (Kassel, Germany)
Drug-induced parkinsonism in Taiwan

J.J. Lin, K.C. Yueh, A.C. Chen (Nantou, Taiwan)
DTI in Parkinson’s disease: Asymmetric progression

L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)
DTI tractographic correlates of weight gain in Parkinson’s disease patients after STN DBS

O.F. Ahmad, L. Huang, N. Vanegas-Arroyave, K. Zaghloul, S.G. Horovitz, C. Lungu (Bethesda, MD, USA)
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, reduces daily OFF time in Parkinson’s disease

M. Tomiyama, Y. Funamizu, T. Kon, R. Haga, T. Ueno, H. Nishijima, A. Arai, C. Suzuki, J.I. Nunomura, M. Baba (Aomori, Japan)
Duodenal levodopa infusion: Safety and efficacy in a 6 years outpatient follow-up

S. Simoni, N. Tambasco, E. Sacchini, P. Nigro, F. Ripandelli, P. Calabresi (Perugia, Italy)
Duodopa for the treatment of severe restless legs syndrome

J. Perez-Perez, B. Pascual-Sedano, A. Campolongo, J. Kulisevsky (Barcelona, Spain)
Duodopa treatment experience in Oradea

M. Sabau, L. Botnaru, A. Badea, C. Dudas (Oradea, Romania)
Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease

S.H. Guptha (Peterborough, United Kingdom)
Dyadic decision making & decisional satisfaction in advanced Parkinson’s disease

B. Habermann, J.Y. Shin (Newark, DE, USA)
Dynamic and static posturographic analysis among fallers and non- faller Parkinson’s disease (PD) patients using Neurocom SMART EquiTest

A. Lieberman, C. Frames, A. Deep, M. McCauley, S. Shafer (Phoenix, AZ, USA)
Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)
Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease

S. Luo, J. Wang (Houston, TX, USA)
Dynamics in statin use, low density lipoprotein cholesterol levels and Parkinson’s disease. A population-based cohort study using big-data

V. Rozani, N. Giladi, B. Elad, T. Gurevich, J. Tsamir, B. Hemo, C. Peretz (Petach Tikva, Israel)
Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation

S. Palermo, M. Amanzio, M. Zibetti, L. Lopiano (Turin, Italy)
Dysphagia in early stage Huntington’s disease (HD) – Pilot observations from a multimodal imaging study

I. Trender-Gerhard, E. Michou, A. Gerhard, D. Craufurd, S. Hamdy, K. Herholz (Manchester, United Kingdom)
Dysregulated macroautophagy and mitochondrial dynamics in PD with glucocerebrosidase mutations

S.H. Kuo, H. Li, A. Ham, M.M. Cheng, Y. Quan, D. Sulzer, G. Tang (New York, NY, USA)
Dysregulations of GABAergic neurotransmission in Huntington’s disease brain

Y.T. Hsu, Y.G. Chang, H.M. Chen, Y. Chern (Taichung, Taiwan)
Dystonia after peripheral nerve injury in DYT1 transgenic rats

S. Knorr, K. Grundmann-Hauser, J. Volkmann, C.W. Ip (Wuerzburg, Germany)
Dystonia in a medieval scribe: Analysis of Bernard Blancard’s handwriting over four decades

D.E. Thorpe, N. Melson, J.E. Alty (York, United Kingdom)
Dystonia-deafness syndrome caused by beta -actin gene mutation and the effect of pallidal deep brain stimulation

H. Eggink, M.E. van Egmond, M.C. Schönherr, C.C. Verschuuren-Bemelmans, T.J. de Koning, M.J.C. van Dijk, M.A.J. Tijssen (Groningen, Netherlands)
Dystonia, myoclonus, and tremor without epilepsy associated with a mutation in STXBP1

L.S. Tochen, C. Applegate, H.S. Singer (Baltimore, MD, USA)
Dystonia, tremor, and dystonic tremor

A.R. Rosen, A.G. Shaikh, H.A. Jinnah (Atlanta, GA, USA)
DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from southern Italy

M. Quadri, S. Olgiati, M. Sensi, F. Gualandi, E. Groppo, V. Rispoli, J. Graafland, G.J. Breedveld, G. Fabbrini, A. Berardelli, V. Bonifati (Rotterdam, Netherlands)
DYT2 dystonia – Too rare to be found?

V. Dobricic, N. Kresojevic, A. Marjanovic, A. Tomic, M. Svetel, I. Novakovic, V. Kostic (Belgrade, Serbia)